Technology area: Biotechnology & Pharmaceuticals
33 pending office actions • 10 clients • 29 examiners • 15 art units • 0 of 33 (0%) have an AI response strategy ready
The profile covers Biotechnology & Pharmaceuticals and shows 34 pending office actions. It records 26696 career applications, placing current activity within a broad application history.
The resolved allowance rate is 86.01%, and the average is 3.22 office actions per allowance. The data connects resolved outcomes with the examination effort preceding allowance. Practitioners can use the allowance rate to frame outcome expectations and the action average to plan responses in biotechnology and pharmaceutical matters.
Based on the USPTO statutory response window for each pending office action. 13 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 13 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (3%) |
| §103 only | 4 (12%) |
| §102 only | 3 (9%) |
| §112 only | 3 (9%) |
| Double-patenting + other | 5 (15%) |
| Multi-statute (no §101) | 17 (52%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KIM, YOUNG J | 2 | 64.8% | +18.2% |
| WILDER, CYNTHIA B | 2 | 70.8% | +27.0% |
| LAFAVE, ELIZABETH ROSE | 2 | 64.4% | +43.2% |
| LU, FRANK WEI MIN | 2 | 62.7% | +67.9% |
| BAE, JI H | 1 | 82.3% | +20.9% |
| CHEN, XUXING | 1 | 86.0% | +11.8% |
| MUMMERT, STEPHANIE KANE | 1 | 61.4% | +21.2% |
| PHAM, KHAI QUYNH TIEN | 1 | 0.0% | +0.0% |
| WU, STEPHANIE | 1 | 81.2% | +18.4% |
| SERRAGUARD, SEAN ERIN | 1 | 69.3% | +34.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18620529 | MULTIPLEXED-RANK DUAL INLINE MEMORY MODULE (MRDIMM) VIRTUAL CONTROLLER MODE | WU, STEPHANIE | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17996196 | A METHOD FOR DETECTION OF WHOLE TRANSCRIPTOME IN SINGLE CELLS | PARISI, JESSICA DANIELLE | 126d overdue |
| 17751023 | METHODS AND SYSTEMS FOR DETERMINING CELL-CELL INTERACTION | LAFAVE, ELIZABETH ROSE | 121d overdue |
| 17421088 | SYSTEMS AND METHODS FOR PHYSIOLOGY MONITORING GARMENT | HADDAD, MOUSSA MAHER | 74d overdue |
| 18614235 | DYNAMIC NATURAL LANGUAGE PROCESSING SYSTEM FOR IMPROVED CONTEXTUAL UNDERSTANDING AND INTERACTIVE RESPONSE | SERRAGUARD, SEAN ERIN | 71d overdue |
| 17373653 | cDNA SPIKE-IN CONTROL FOR SINGLE CELL ANALYSIS | YU, TIAN NMN | 51d overdue |
| 18392707 | SMART COLUMN ADDRESS STROBE (CAS) BURST CONTINUATION | DARE, RYAN A | 17d overdue |
| 17421173 | SYSTEMS AND METHODS FOR PHYSIOLOGY MONITORING KNEE BRACE | FEDORKY, MEGAN TAYLOR | 17d overdue |
| 17923506 | COMPOSITIONS AND METHODS FOR MODIFYING POLYMERASE-NUCLEIC ACID COMPLEXES | LAFAVE, ELIZABETH ROSE | 15d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17751023 | METHODS AND SYSTEMS FOR DETERMINING CELL-CELL INTERACTION | LAFAVE, ELIZABETH ROSE | 121d overdue |
| 18614235 | DYNAMIC NATURAL LANGUAGE PROCESSING SYSTEM FOR IMPROVED CONTEXTUAL UNDERSTANDING AND INTERACTIVE RESPONSE | SERRAGUARD, SEAN ERIN | 71d overdue |
| 17923506 | COMPOSITIONS AND METHODS FOR MODIFYING POLYMERASE-NUCLEIC ACID COMPLEXES | LAFAVE, ELIZABETH ROSE | 15d |
| 17822948 | MEASUREMENT OF PROTEIN EXPRESSION USING REAGENTS WITH BARCODED OLIGONUCLEOTIDE SEQUENCES | LU, FRANK WEI MIN | 71d |
| 19195264 | READ CLOCK START AND STOP FOR SYNCHRONOUS MEMORIES | BAE, JI H | — |
| 19033094 | Universal Declarative Framework for Automating Data Pipelines | CHEN, XUXING | — |
| 18730043 | PREPARING NUCLEIC ACID FOR FURTHER ANALYSIS OF THEIR SEQUENCE | KIM, YOUNG J | — |
| 18721639 | NON-OPAQUE LYTIC BUFFER COMPOSITION FORMULATIONS | MUMMERT, STEPHANIE KANE | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Becton Dickinson | 18 |
| AMD | 4 |
| MGI | 3 |
| NATCO PHARMA LIMITED | 2 |
| Schemon Inc. | 1 |
| Kamazooie Development Corporation | 1 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 1 |
| SINGLERON (NANJING) BIOTECHNOLOGIES, LTD. | 1 |
| Singleron Biotechnologies Inc. | 1 |
| CELLULAR RESEARCH, INC. | 1 |
| Art Unit | Apps |
|---|---|
| 1681 | 7 |
| 1684 | 6 |
| 1682 | 4 |
| 2176 | 2 |
| 1683 | 2 |
| 3796 | 2 |
| 1639 | 1 |
| 2133 | 1 |
| 2657 | 1 |
| 1624 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19195264 | READ CLOCK START AND STOP FOR SYNCHRONOUS MEMORIES | Advanced Micro Devices, Inc. | BAE, JI H | 2176 | §102§103§112Other | Non-Final OA | — | Pending | Apr 30, 2025 |
| 19033094 | Universal Declarative Framework for Automating Data Pipelines | Schemon Inc. | CHEN, XUXING | 2176 | §103§112 | Non-Final OA | — | Pending | Jan 21, 2025 |
| 18730043 | PREPARING NUCLEIC ACID FOR FURTHER ANALYSIS OF THEIR SEQUENCE | BECTON, DICKINSON AND COMPANY | KIM, YOUNG J | 1681 | §102 | Non-Final OA | — | Pending | Jul 18, 2024 |
| 18721639 | NON-OPAQUE LYTIC BUFFER COMPOSITION FORMULATIONS | BECTON, DICKINSON AND COMPANY | MUMMERT, STEPHANIE KANE | 1681 | §102§103§112 | Non-Final OA | — | Pending | Jun 18, 2024 |
| 18652519 | DIGITAL COUNTING OF INDIVIDUAL MOLECULES BY STOCHASTIC ATTACHMENT OF DIVERSE LABELS | BECTON, DICKINSON AND COMPANY | PHAM, KHAI QUYNH TIEN | 1639 | §102§103 | Non-Final OA | — | Pending | May 01, 2024 |
| 18620529 | MULTIPLEXED-RANK DUAL INLINE MEMORY MODULE (MRDIMM) VIRTUAL CONTROLLER MODE | Advanced Micro Devices, Inc. | WU, STEPHANIE | 2133 | §103 | Non-Final OA | — | Pending | Mar 28, 2024 |
| 18614235 | DYNAMIC NATURAL LANGUAGE PROCESSING SYSTEM FOR IMPROVED CONTEXTUAL UNDERSTANDING AND INTERACTIVE RESPONSE | Kamazooie Development Corporation | SERRAGUARD, SEAN ERIN | 2657 | §102§103§112 | Final Rejection | 71d overdue | Pending | Mar 22, 2024 |
| 18692678 | AN IMPROVED PROCESS FOR THE PREPARATION OF RUXOLITINIB PHOSPHATE | Natco Pharma Limited | MOORE, SUSANNA | 1624 | §103§112 | Non-Final OA | — | Pending | Mar 15, 2024 |
| 18688919 | NON-SEQUENCING PCR-BASED METHOD FOR DETECTION OF ANTIBODY-CONJUGATED OLIGONUCLEOTIDES | BECTON, DICKINSON AND COMPANY | WILDER, CYNTHIA B | 1681 | §112DP | Non-Final OA | — | Pending | Mar 04, 2024 |
| 18686927 | AN IMPROVED PROCESS FOR THE PREPARATION OF TRABECTEDIN | Natco Pharma Limited | CORNET, JEAN P | 1628 | §103 | Final Rejection | — | Pending | Feb 27, 2024 |
| 18687030 | SPATIAL MULTIOMICS USING IN SITU REVERSE TRANSCRIPTION | BECTON, DICKINSON AND COMPANY | POHNERT, STEVEN C | §102§103§112Other | Final Rejection | — | Pending | Feb 27, 2024 | |
| 18686812 | USE OF DECOY POLYNUCLEOTIDES IN SINGLE CELL MULTIOMICS | BECTON, DICKINSON AND COMPANY | KIM, YOUNG J | 1681 | §103§112 | Non-Final OA | — | Pending | Feb 26, 2024 |
| 18418143 | ASSAY FOR DETECTING CLOSELY-RELATED SEROTYPES OF HUMAN PAPILLOMAVIRUS (HPV) | BECTON, DICKINSON AND COMPANY | WILDER, CYNTHIA B | 1681 | §112DP | Non-Final OA | — | Pending | Jan 19, 2024 |
| 18392707 | SMART COLUMN ADDRESS STROBE (CAS) BURST CONTINUATION | Advanced Micro Devices, Inc. | DARE, RYAN A | 2132 | §102§103 | Non-Final OA | 17d overdue | Pending | Dec 21, 2023 |
| 18572149 | SMART GARMENT FOR REMOTE DELIVERY OF THERAPY | Mgi Holdco Ltd. | LUAN, SCOTT | 3792 | §102§103 | Final Rejection | 72d | Pending | Dec 19, 2023 |
| 18558035 | METHODS FOR MAKING LIBRARIES FOR NUCLEIC ACID SEQUENCING | BECTON, DICKINSON AND COMPANY | TSUI, YUNG-SHENG M | 1684 | §102§103DP | Final Rejection | — | Pending | Oct 30, 2023 |
| 18374153 | EFFICIENT BUS TURNAROUND FOR MEMORY CONTROLLER | Advanced Micro Devices, Inc. | LI, SIDNEY | 2137 | §102 | Final Rejection | — | Pending | Sep 28, 2023 |
| 18548972 | ISOTHERMAL AMPLIFICATION OF PATHOGENS | BECTON, DICKINSON AND COMPANY | HANEY, AMANDA MARIE | 1682 | §103§112 | Non-Final OA | — | Pending | Sep 05, 2023 |
| 18251536 | RAPID IDENTIFICATION AND TYPING OF VIBRIO PARAHAEMOLYTICUS | BECTON, DICKINSON AND COMPANY | SWITZER, JULIET CAROLINE | 1682 | §103§112 | Non-Final OA | — | Pending | May 03, 2023 |
| 18251528 | MULTIPLEX DETECTION OF BACTERIAL RESPIRATORY PATHOGENS | BECTON, DICKINSON AND COMPANY | GOLDBERG, JEANINE ANNE | 1682 | §103 | Final Rejection | 28d overdue | Pending | May 02, 2023 |
| 18194590 | MASSIVELY PARALLEL SINGLE CELL ANALYSIS | BECTON, DICKINSON AND COMPANY | PRIEST, AARON A | 1681 | §103DP | Final Rejection | — | Pending | Mar 31, 2023 |
| 18187449 | METHODS AND COMPOSITIONS FOR QUANTITATION OF PROTEINS AND RNA | BECTON, DICKINSON AND COMPANY | ZHANG, KAIJIANG | 1684 | §102Other | Non-Final OA | — | Pending | Mar 21, 2023 |
| 18058216 | METHODS AND COMPOSITIONS FOR COMBINATORIAL BARCODING | BECTON, DICKINSON AND COMPANY | HAVLIN, ROBERT H | 1626 | §102§103DP | Final Rejection | 54d | Pending | Nov 22, 2022 |
| 17923506 | COMPOSITIONS AND METHODS FOR MODIFYING POLYMERASE-NUCLEIC ACID COMPLEXES | Pacific Biosciences of California, Inc. | LAFAVE, ELIZABETH ROSE | 1684 | §102§103 | Non-Final OA | 15d | Pending | Nov 04, 2022 |
| 17996196 | A METHOD FOR DETECTION OF WHOLE TRANSCRIPTOME IN SINGLE CELLS | Singleron (Nanjing) Biotechnologies, Ltd. | PARISI, JESSICA DANIELLE | 1684 | §102§112 | Final Rejection | 126d overdue | Pending | Oct 13, 2022 |
| 17822948 | MEASUREMENT OF PROTEIN EXPRESSION USING REAGENTS WITH BARCODED OLIGONUCLEOTIDE SEQUENCES | BECTON, DICKINSON AND COMPANY | LU, FRANK WEI MIN | 1683 | §112 | Final Rejection | 71d | Pending | Aug 29, 2022 |
| 17821449 | MEASUREMENT OF PROTEIN EXPRESSION USING REAGENTS WITH BARCODED OLIGONUCLEOTIDE SEQUENCES | BECTON, DICKINSON AND COMPANY | LU, FRANK WEI MIN | 1683 | §112 | Non-Final OA | — | Pending | Aug 22, 2022 |
| 17751023 | METHODS AND SYSTEMS FOR DETERMINING CELL-CELL INTERACTION | Singleron Biotechnologies Inc. | LAFAVE, ELIZABETH ROSE | 1684 | §102§103 | Final Rejection | 121d overdue | Pending | May 23, 2022 |
| 17684289 | METHODS AND COMPOSITIONS FOR WHOLE TRANSCRIPTOME AMPLIFICATION | BECTON, DICKINSON AND COMPANY | FLINDERS, JEREMY C | 1682 | §103 | Non-Final OA | — | Pending | Mar 01, 2022 |
| 17373653 | cDNA SPIKE-IN CONTROL FOR SINGLE CELL ANALYSIS | BECTON, DICKINSON AND COMPANY | YU, TIAN NMN | 1681 | §103§112 | Non-Final OA | 51d overdue | Pending | Jul 12, 2021 |
| 17421173 | SYSTEMS AND METHODS FOR PHYSIOLOGY MONITORING KNEE BRACE | Mgi Holdco Ltd. | FEDORKY, MEGAN TAYLOR | 3796 | §101§103 | Non-Final OA | 17d overdue | Pending | Jul 07, 2021 |
| 17421088 | SYSTEMS AND METHODS FOR PHYSIOLOGY MONITORING GARMENT | Mgi Holdco. Ltd. | HADDAD, MOUSSA MAHER | 3796 | §103§112 | Final Rejection | 74d overdue | Pending | Jul 07, 2021 |
| 16551620 | SAMPLE MULTIPLEXING USING CARBOHYDRATE-BINDING AND MEMBRANE-PERMEABLE REAGENTS | Cellular Research, Inc. | BUNKER, AMY M | 1684 | §112 | Non-Final OA | 19d | Pending | Aug 26, 2019 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial86.0% of resolved applications prosecuted by Dickinson Wright, PLLC were allowed, across 26,696 applications in USPTO records.
3.22 office actions per allowed application on average.
33 pending office actions as of October 2026, for 10 clients, before 29 examiners in 15 art units.
